Evidence for lack of enhanced hedgehog target gene expression in common extracutaneous tumors

Zhilan Hu1, Jeannette M Bonifas, Geraldine Aragon

  • 1The Cooperative Human Tissue Network, University of Alabama, Birmingham, AL 35294, USA.

Cancer Research
|March 5, 2003
PubMed

Insights

Abnormal hedgehog signaling drives basal cell carcinoma (BCC) growth. This study found that hedgehog pathway dysregulation is not common in other common cancers, suggesting BCCs have unique molecular drivers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Abnormal hedgehog signaling, often due to PTCH1 inhibitor loss, is a key driver of basal cell carcinoma (BCC) tumorigenesis.
  • Understanding the role of hedgehog signaling in other cancers is crucial for comparative oncology and targeted therapy development.

Purpose of the Study:

  • To investigate the prevalence of hedgehog signaling pathway dysregulation in common non-BCC cancers.
  • To compare the molecular pathogenesis of BCCs with other cancer types.

Main Methods:

  • Assayed RNA expression levels of hedgehog target genes in common cancers from nine different sites.
  • Compared gene expression patterns with those uniformly up-regulated in BCCs.

Main Results:

  • Dysregulation of hedgehog target genes was found to be uncommon in the studied non-BCC cancer types.
  • The molecular pathways driving BCCs appear distinct from those in most other common cancers.

Conclusions:

  • The hedgehog signaling pathway's role in tumorigenesis is specific to basal cell carcinomas among the common cancers examined.
  • Basal cell carcinoma's molecular pathogenesis differs significantly from that of other major cancer types.